RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 104 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,948,000 | -66.9% | 1,041,612 | -58.6% | 0.02% | -71.1% |
| Q1 2018 | $8,917,000 | -8.8% | 2,518,882 | 0.0% | 0.08% | -10.6% |
| Q4 2017 | $9,773,000 | +52.8% | 2,518,882 | 0.0% | 0.08% | +63.5% |
| Q3 2017 | $6,398,000 | -7.0% | 2,518,882 | 0.0% | 0.05% | -13.3% |
| Q2 2017 | $6,877,000 | -17.5% | 2,518,882 | 0.0% | 0.06% | -11.8% |
| Q1 2017 | $8,337,000 | +73.5% | 2,518,882 | +24.8% | 0.07% | +44.7% |
| Q4 2016 | $4,805,000 | +276.9% | 2,018,882 | +465.2% | 0.05% | +327.3% |
| Q1 2015 | $1,275,000 | +16.5% | 357,187 | -25.9% | 0.01% | 0.0% |
| Q4 2014 | $1,094,000 | +17.0% | 481,972 | 0.0% | 0.01% | -8.3% |
| Q3 2014 | $935,000 | -46.6% | 481,972 | 0.0% | 0.01% | -42.9% |
| Q2 2014 | $1,750,000 | -6.4% | 481,972 | 0.0% | 0.02% | -12.5% |
| Q1 2014 | $1,870,000 | +31.2% | 481,972 | -3.6% | 0.02% | +20.0% |
| Q4 2013 | $1,425,000 | -20.4% | 500,000 | 0.0% | 0.02% | -20.0% |
| Q3 2013 | $1,790,000 | – | 500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |